1755. Deputy Marie Sherlock asked the Minister for Health if durvalumab is being considered for use by the HSE as part of the first-line treatment of patients with cholangiocarcinoma (bile duct cancer) as is now the case in the United Kingdom; and if she will make a statement on the matter. [11901/25]

Summary

1755. Deputy Marie Sherlock asked the Minister for Health if durvalumab is being considered for use by the HSE as part of the first-line treatment of patients with cholangiocarcinoma (bile duct cancer) as is now the case in the United Kingdom; and if she will make a statement on the matter. [11901/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 19 March 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.